InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Bumpus Namandje. Officer active across 1 company, notably Recursion Pharmaceuticals, INC.. Aggregated, 5 filings have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €13k. History available since 17 March 2025. The latest transaction was filed on 3 June 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Bumpus Namandje is a declarant linked to Recursion Pharmaceuticals, INC., where he is Director. He has 5 filings in total, and among the sampled recent filings, sales total 13368 EUR, with filings dated from 2025-03-19 to 2026-06-22.